Adimab partners with biopharma leaders to unlock the full potential of protein-based therapeutics
Adimab partners with biopharma leaders to unlock the full potential of protein-based therapeutics. Utilizing a highly engineered yeast strain and a team of experienced scientists, Adimab delivers candidates that transform patients’ lives.